A Systematic Review on Marine Algae-Derived Fucoxanthin: An Update of Pharmacological Insights
Fucoxanthin, belonging to the xanthophyll class of carotenoids, is a natural antioxidant pigment of marine algae, including brown macroalgae and diatoms. It represents 10% of the total carotenoids in nature. The plethora of scientific evidence supports the potential benefits of nutraceutical and pha...
Saved in:
Published in | Marine drugs Vol. 20; no. 5; p. 279 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
22.04.2022
MDPI |
Subjects | |
Online Access | Get full text |
ISSN | 1660-3397 1660-3397 |
DOI | 10.3390/md20050279 |
Cover
Loading…
Abstract | Fucoxanthin, belonging to the xanthophyll class of carotenoids, is a natural antioxidant pigment of marine algae, including brown macroalgae and diatoms. It represents 10% of the total carotenoids in nature. The plethora of scientific evidence supports the potential benefits of nutraceutical and pharmaceutical uses of fucoxanthin for boosting human health and disease management. Due to its unique chemical structure and action as a single compound with multi-targets of health effects, it has attracted mounting attention from the scientific community, resulting in an escalated number of scientific publications from January 2017 to February 2022. Fucoxanthin has remained the most popular option for anti-cancer and anti-tumor activity, followed by protection against inflammatory, oxidative stress-related, nervous system, obesity, hepatic, diabetic, kidney, cardiac, skin, respiratory and microbial diseases, in a variety of model systems. Despite much pharmacological evidence from in vitro and in vivo findings, fucoxanthin in clinical research is still not satisfactory, because only one clinical study on obesity management was reported in the last five years. Additionally, pharmacokinetics, safety, toxicity, functional stability, and clinical perspective of fucoxanthin are substantially addressed. Nevertheless, fucoxanthin and its derivatives are shown to be safe, non-toxic, and readily available upon administration. This review will provide pharmacological insights into fucoxanthin, underlying the diverse molecular mechanisms of health benefits. However, it requires more activity-oriented translational research in humans before it can be used as a multi-target drug. |
---|---|
AbstractList | Fucoxanthin, belonging to the xanthophyll class of carotenoids, is a natural antioxidant pigment of marine algae, including brown macroalgae and diatoms. It represents 10% of the total carotenoids in nature. The plethora of scientific evidence supports the potential benefits of nutraceutical and pharmaceutical uses of fucoxanthin for boosting human health and disease management. Due to its unique chemical structure and action as a single compound with multi-targets of health effects, it has attracted mounting attention from the scientific community, resulting in an escalated number of scientific publications from January 2017 to February 2022. Fucoxanthin has remained the most popular option for anti-cancer and anti-tumor activity, followed by protection against inflammatory, oxidative stress-related, nervous system, obesity, hepatic, diabetic, kidney, cardiac, skin, respiratory and microbial diseases, in a variety of model systems. Despite much pharmacological evidence from in vitro and in vivo findings, fucoxanthin in clinical research is still not satisfactory, because only one clinical study on obesity management was reported in the last five years. Additionally, pharmacokinetics, safety, toxicity, functional stability, and clinical perspective of fucoxanthin are substantially addressed. Nevertheless, fucoxanthin and its derivatives are shown to be safe, non-toxic, and readily available upon administration. This review will provide pharmacological insights into fucoxanthin, underlying the diverse molecular mechanisms of health benefits. However, it requires more activity-oriented translational research in humans before it can be used as a multi-target drug. Fucoxanthin, belonging to the xanthophyll class of carotenoids, is a natural antioxidant pigment of marine algae, including brown macroalgae and diatoms. It represents 10% of the total carotenoids in nature. The plethora of scientific evidence supports the potential benefits of nutraceutical and pharmaceutical uses of fucoxanthin for boosting human health and disease management. Due to its unique chemical structure and action as a single compound with multi-targets of health effects, it has attracted mounting attention from the scientific community, resulting in an escalated number of scientific publications from January 2017 to February 2022. Fucoxanthin has remained the most popular option for anti-cancer and anti-tumor activity, followed by protection against inflammatory, oxidative stress-related, nervous system, obesity, hepatic, diabetic, kidney, cardiac, skin, respiratory and microbial diseases, in a variety of model systems. Despite much pharmacological evidence from in vitro and in vivo findings, fucoxanthin in clinical research is still not satisfactory, because only one clinical study on obesity management was reported in the last five years. Additionally, pharmacokinetics, safety, toxicity, functional stability, and clinical perspective of fucoxanthin are substantially addressed. Nevertheless, fucoxanthin and its derivatives are shown to be safe, non-toxic, and readily available upon administration. This review will provide pharmacological insights into fucoxanthin, underlying the diverse molecular mechanisms of health benefits. However, it requires more activity-oriented translational research in humans before it can be used as a multi-target drug.Fucoxanthin, belonging to the xanthophyll class of carotenoids, is a natural antioxidant pigment of marine algae, including brown macroalgae and diatoms. It represents 10% of the total carotenoids in nature. The plethora of scientific evidence supports the potential benefits of nutraceutical and pharmaceutical uses of fucoxanthin for boosting human health and disease management. Due to its unique chemical structure and action as a single compound with multi-targets of health effects, it has attracted mounting attention from the scientific community, resulting in an escalated number of scientific publications from January 2017 to February 2022. Fucoxanthin has remained the most popular option for anti-cancer and anti-tumor activity, followed by protection against inflammatory, oxidative stress-related, nervous system, obesity, hepatic, diabetic, kidney, cardiac, skin, respiratory and microbial diseases, in a variety of model systems. Despite much pharmacological evidence from in vitro and in vivo findings, fucoxanthin in clinical research is still not satisfactory, because only one clinical study on obesity management was reported in the last five years. Additionally, pharmacokinetics, safety, toxicity, functional stability, and clinical perspective of fucoxanthin are substantially addressed. Nevertheless, fucoxanthin and its derivatives are shown to be safe, non-toxic, and readily available upon administration. This review will provide pharmacological insights into fucoxanthin, underlying the diverse molecular mechanisms of health benefits. However, it requires more activity-oriented translational research in humans before it can be used as a multi-target drug. |
Author | Mohibbullah, Md Uddin, Md. Jamal Choi, Jae-Suk Hossain, Md. Tahmeed Hannan, Md. Abdul Zahan, Md. Sarwar Moon, Il Soo Haque, Md. Nazmul Sohag, Abdullah Al Mamun |
AuthorAffiliation | 2 Seafood Research Center, Silla University, #605, Advanced Seafood Processing Complex, Wonyang-ro, Amnam-dong, Seo-gu, Busan 49277, Korea 1 Department of Fishing and Post Harvest Technology, Sher-e-Bangla Agricultural University, Sher-e-Bangla Nagar, Dhaka 1207, Bangladesh; mmohib.fpht@sau.edu.bd 5 Department of Fisheries Biology and Genetics, Patuakhali Science and Technology University, Patuakhali 8602, Bangladesh 7 ABEx Bio-Research Center, East Azampur, Dhaka 1230, Bangladesh; mszahan@hotmail.com (M.S.Z.); hasan800920@gmail.com (M.J.U.) 4 Department of Anatomy, College of Medicine, Dongguk University, Gyeongju 38066, Korea; habib.332@gmail.com (M.N.H.); moonis@dongguk.ac.kr (I.S.M.) 6 Department of Biochemistry and Molecular Biology, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh; sohag2010bmb.sust@gmail.com (A.A.M.S.); tahmeed.hossain@bau.edu.bd (M.T.H.); hannanbmb@bau.edu.bd (M.A.H.) 3 Department of Food Biotechnology, Division of Bioindustry, College of Medical and L |
AuthorAffiliation_xml | – name: 7 ABEx Bio-Research Center, East Azampur, Dhaka 1230, Bangladesh; mszahan@hotmail.com (M.S.Z.); hasan800920@gmail.com (M.J.U.) – name: 4 Department of Anatomy, College of Medicine, Dongguk University, Gyeongju 38066, Korea; habib.332@gmail.com (M.N.H.); moonis@dongguk.ac.kr (I.S.M.) – name: 5 Department of Fisheries Biology and Genetics, Patuakhali Science and Technology University, Patuakhali 8602, Bangladesh – name: 3 Department of Food Biotechnology, Division of Bioindustry, College of Medical and Life Sciences, Silla University, Busan 46958, Korea – name: 1 Department of Fishing and Post Harvest Technology, Sher-e-Bangla Agricultural University, Sher-e-Bangla Nagar, Dhaka 1207, Bangladesh; mmohib.fpht@sau.edu.bd – name: 6 Department of Biochemistry and Molecular Biology, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh; sohag2010bmb.sust@gmail.com (A.A.M.S.); tahmeed.hossain@bau.edu.bd (M.T.H.); hannanbmb@bau.edu.bd (M.A.H.) – name: 2 Seafood Research Center, Silla University, #605, Advanced Seafood Processing Complex, Wonyang-ro, Amnam-dong, Seo-gu, Busan 49277, Korea |
Author_xml | – sequence: 1 givenname: Md orcidid: 0000-0002-7845-5908 surname: Mohibbullah fullname: Mohibbullah, Md – sequence: 2 givenname: Md. Nazmul surname: Haque fullname: Haque, Md. Nazmul – sequence: 3 givenname: Abdullah Al Mamun orcidid: 0000-0001-9084-2364 surname: Sohag fullname: Sohag, Abdullah Al Mamun – sequence: 4 givenname: Md. Tahmeed orcidid: 0000-0003-3603-669X surname: Hossain fullname: Hossain, Md. Tahmeed – sequence: 5 givenname: Md. Sarwar orcidid: 0000-0001-5768-4317 surname: Zahan fullname: Zahan, Md. Sarwar – sequence: 6 givenname: Md. Jamal orcidid: 0000-0003-2911-3255 surname: Uddin fullname: Uddin, Md. Jamal – sequence: 7 givenname: Md. Abdul orcidid: 0000-0001-6640-4495 surname: Hannan fullname: Hannan, Md. Abdul – sequence: 8 givenname: Il Soo orcidid: 0000-0002-1608-016X surname: Moon fullname: Moon, Il Soo – sequence: 9 givenname: Jae-Suk orcidid: 0000-0002-8151-6054 surname: Choi fullname: Choi, Jae-Suk |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35621930$$D View this record in MEDLINE/PubMed |
BookMark | eNptkk1v1DAQhiNURD_gwg9AlrggpMAkTpwNh0qrQmGlIhDQK9bYnux6ldiLnSz03-NlW2grTrZmnnn1zsdxduC8oyx7WsArzlt4PZgSoIayaR9kR4UQkKdwc3Drf5gdx7gG4PWsrR5lh7wWZdFyOMq-z9nXqzjSgKPV7AttLf1k3rGPGKwjNu-XSPlbCnZLhp1P2v9CN66se8Pmjl1uDI7EfMc-rzAMqH3vl1ZjzxYu2uVqjI-zhx32kZ5cvyfZ5fm7b2cf8otP7xdn84tcV0055qoRM92SoAaNxkq0RUWdJkLFwTStghoVdMIUHGAGXaeUQqy7RlGhUQvgJ9lir2s8ruUm2AHDlfRo5Z-AD0uJIXXYkzTcKN2WGmtjqmoGSgijqWsBoaIau6R1utfaTGqglHNjwP6O6N2Msyu59FuZXIvUSBJ4cS0Q_I-J4igHGzX1PTryU5SlaIqyqeuySOjze-jaT8GlUe0o4GkUlUjUs9uO_lq5WWMCYA_o4GMM1Eltx7RRvzNoe1mA3F2K_HcpqeTlvZIb1f_AvwEVnL_H |
CitedBy_id | crossref_primary_10_3390_md21060340 crossref_primary_10_3390_nu15020464 crossref_primary_10_3390_md20100592 crossref_primary_10_1016_j_fbio_2024_103774 crossref_primary_10_1016_j_fbio_2024_104421 crossref_primary_10_3390_molecules27196713 crossref_primary_10_1016_j_ijbiomac_2024_130264 crossref_primary_10_1007_s12033_024_01173_y crossref_primary_10_1021_acs_jafc_4c00590 crossref_primary_10_3390_molecules29010061 crossref_primary_10_1016_j_phanu_2025_100432 crossref_primary_10_3390_md20100618 crossref_primary_10_3390_md22070327 crossref_primary_10_31857_S0134347523030099 crossref_primary_10_3390_ph17070960 crossref_primary_10_3390_life13091831 crossref_primary_10_1017_erm_2023_18 crossref_primary_10_1038_s41598_024_83909_z crossref_primary_10_3390_macromol5010011 crossref_primary_10_3390_nu15081954 crossref_primary_10_3390_md22020093 crossref_primary_10_1134_S1063074023030094 crossref_primary_10_4103_jmau_jmau_104_24 crossref_primary_10_3390_cells12071053 crossref_primary_10_37349_eaa_2024_00035 crossref_primary_10_1039_D3FO02633G crossref_primary_10_1016_j_intimp_2023_110370 crossref_primary_10_3390_ijms24065388 crossref_primary_10_3390_md23020066 crossref_primary_10_1016_j_mtsust_2024_100935 crossref_primary_10_3390_app12199452 crossref_primary_10_1016_j_algal_2025_103990 crossref_primary_10_1111_pai_13979 crossref_primary_10_3390_ijms23158301 crossref_primary_10_3390_md21070391 crossref_primary_10_3390_foods12173167 crossref_primary_10_1002_fsn3_3265 crossref_primary_10_37349_ent_2023_00058 crossref_primary_10_1007_s43630_023_00407_3 crossref_primary_10_1016_j_brainresbull_2022_11_018 crossref_primary_10_1016_j_phytol_2024_03_009 crossref_primary_10_1186_s43014_023_00155_y crossref_primary_10_3390_molecules28073267 crossref_primary_10_1021_acs_jafc_4c03677 crossref_primary_10_1016_j_oor_2024_100552 crossref_primary_10_61186_jambr_32_151_135 crossref_primary_10_1016_j_tifs_2024_104760 crossref_primary_10_1016_j_jff_2022_105359 |
Cites_doi | 10.1016/j.btre.2018.e00296 10.1615/JEnvironPatholToxicolOncol.2019030997 10.1155/2021/6688708 10.3390/molecules26144198 10.3390/antiox9040328 10.1007/s11064-016-2123-6 10.3390/md13106521 10.1080/21655979.2021.1973875 10.2131/jts.34.501 10.3322/caac.21660 10.3390/md17010069 10.1016/j.jksus.2020.01.027 10.4314/tjpr.v19i5.4 10.3390/md19020092 10.3390/md9101806 10.1007/s13577-017-0188-4 10.3390/md19110606 10.1021/acs.jafc.7b00805 10.1021/jf050926w 10.3390/md17120702 10.1017/S0007114508199007 10.1039/C9FO01018A 10.1007/s10811-018-1458-6 10.1021/acsomega.9b00871 10.1053/j.ajkd.2011.02.385 10.3390/jcm9010090 10.2174/1381612826666200628022812 10.1021/acs.jafc.6b04376 10.3389/fnmol.2020.00116 10.1016/j.tifs.2021.03.012 10.1002/fsn3.2301 10.3390/jcm11041136 10.1208/s12248-022-00679-0 10.3390/molecules26144288 10.3390/md19030132 10.1038/srep46763 10.1208/s12248-018-0197-6 10.1038/s41598-020-80748-6 10.3390/ijms21062180 10.3390/nu11040796 10.1186/s12906-018-2164-2 10.1007/s12011-020-02291-9 10.1080/16546628.2017.1304678 10.3390/md19060334 10.1177/0300060520964011 10.1158/1940-6207.CAPR-08-0193 10.3390/md17050304 10.3390/md19060307 10.3390/biomedicines9060620 10.1016/j.neuint.2019.01.010 10.3390/ijms20184485 10.3390/antiox9121176 10.2174/1567205018666211118144602 10.3390/md17030152 10.3390/nu13041079 10.1146/annurev.immunol.24.021605.090646 10.1007/s11802-019-4019-y 10.1038/ki.2013.153 10.1016/j.jep.2020.113302 10.3390/md16090323 10.3390/antiox10071092 10.1615/JEnvironPatholToxicolOncol.2019030301 10.1016/j.jnutbio.2021.108871 10.1021/acs.jafc.1c00569 10.3389/fphar.2019.00906 10.3390/md17050311 10.1155/2017/6792543 10.1021/acs.chemrestox.0c00235 10.1007/s00394-021-02509-z 10.3390/pharmaceutics12020136 10.1016/j.biopha.2018.07.088 10.3390/md17100552 10.3164/jcbn.16-112 10.1002/ddr.21451 10.1089/ham.2015.0109 10.3136/nskkk.55.304 10.1016/j.bbrc.2020.05.050 10.1039/D0FO00442A 10.1016/j.jff.2018.07.048 10.1002/aocs.12092 10.1016/j.bbrc.2017.11.022 10.3390/md18110557 10.21873/anticanres.14703 10.20944/preprints202005.0342.v1 10.1615/JEnvironPatholToxicolOncol.2019030154 10.1016/j.toxrep.2021.02.005 10.3390/antiox8080239 10.3390/md16100378 10.1016/j.algal.2021.102187 10.3390/antiox8060183 10.1016/j.jhep.2018.09.014 10.1080/14786419.2018.1528593 10.31989/ffhd.v7i4.333 10.1016/j.ejphar.2021.174629 10.1016/j.jff.2017.07.009 10.1021/acs.jafc.0c01467 10.1016/j.etap.2018.02.006 10.1007/s11011-018-0368-2 10.3390/foods9081113 10.1111/jcmm.14151 10.1016/j.jff.2019.103542 10.1002/mnfr.202000405 10.3390/ijms222413620 10.3390/cells10061311 10.21873/anticanres.14887 |
ContentType | Journal Article |
Copyright | 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 by the authors. 2022 |
Copyright_xml | – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 by the authors. 2022 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T7 7TN 7X7 7XB 88E 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI BKSAR C1K CCPQU DWQXO F1W FR3 FYUFA GHDGH GNUQQ H95 H99 HCIFZ K9. L.F L.G LK8 M0S M1P M7P P64 PCBAR PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.3390/md20050279 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Industrial and Applied Microbiology Abstracts (Microbiology A) Oceanic Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection Earth, Atmospheric & Aquatic Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea ASFA: Aquatic Sciences and Fisheries Abstracts Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources ASFA: Marine Biotechnology Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Aquatic Science & Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts Aquatic Science & Fisheries Abstracts (ASFA) Professional Biological Sciences ProQuest Health & Medical Collection Medical Database ProQuest Biological Science Database (NC LIVE) Biotechnology and BioEngineering Abstracts ProQuest Earth, Atmospheric & Aquatic Science Database (NC LIVE) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Aquatic Science & Fisheries Abstracts (ASFA) Professional ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central Earth, Atmospheric & Aquatic Science Collection ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Oceanic Abstracts Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection Aquatic Science & Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Earth, Atmospheric & Aquatic Science Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ASFA: Aquatic Sciences and Fisheries Abstracts Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1660-3397 |
ExternalDocumentID | oai_doaj_org_article_d3dbc92ca5dd4480b66dcef90a04e5af PMC9146768 35621930 10_3390_md20050279 |
Genre | Systematic Review Journal Article |
GrantInformation_xml | – fundername: This research was funded by the National Research Foundation of Korea (NRF) through Brain Pool Program grantid: Grant No. 2021H1D3A2A01100053 |
GroupedDBID | --- 29M 2WC 53G 5GY 5VS 7X7 88E 8CJ 8FE 8FH 8FI 8FJ AADQD AAHBH AAYXX ABUWG ACGFO ACIHN ACPRK ADBBV AEAQA AENEX AEUYN AFKRA AFRAH AFZYC AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BBNVY BCNDV BENPR BHPHI BKSAR BPHCQ BVXVI CCPQU CITATION CS3 D1J DIK DU5 E3Z EBD EDH F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IHR ITC KQ8 LK5 LK8 M1P M48 M7P M7R MK0 MODMG M~E O5R O5S OK1 OVT P2P PCBAR PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RNS RPM TR2 UKHRP XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 3V. 7T7 7TN 7XB 8FD 8FK AZQEC C1K DWQXO F1W FR3 GNUQQ H95 H99 K9. L.F L.G P64 PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c472t-b768c9e6e7adca46914efceeab30d79b05ab0f6d130080ffbbbaa5f7be1cac603 |
IEDL.DBID | M48 |
ISSN | 1660-3397 |
IngestDate | Wed Aug 27 01:24:13 EDT 2025 Thu Aug 21 18:00:11 EDT 2025 Thu Jul 10 18:28:30 EDT 2025 Fri Jul 25 10:40:21 EDT 2025 Mon Jul 21 06:05:16 EDT 2025 Tue Jul 01 03:19:50 EDT 2025 Thu Apr 24 23:14:53 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | pharmacokinetics safety and toxicity in vivo fucoxanthin in vitro bioactivities |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c472t-b768c9e6e7adca46914efceeab30d79b05ab0f6d130080ffbbbaa5f7be1cac603 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
ORCID | 0000-0002-7845-5908 0000-0003-3603-669X 0000-0003-2911-3255 0000-0002-8151-6054 0000-0002-1608-016X 0000-0001-6640-4495 0000-0001-9084-2364 0000-0001-5768-4317 |
OpenAccessLink | https://doaj.org/article/d3dbc92ca5dd4480b66dcef90a04e5af |
PMID | 35621930 |
PQID | 2670346946 |
PQPubID | 2032365 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d3dbc92ca5dd4480b66dcef90a04e5af pubmedcentral_primary_oai_pubmedcentral_nih_gov_9146768 proquest_miscellaneous_2671275521 proquest_journals_2670346946 pubmed_primary_35621930 crossref_citationtrail_10_3390_md20050279 crossref_primary_10_3390_md20050279 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20220422 |
PublicationDateYYYYMMDD | 2022-04-22 |
PublicationDate_xml | – month: 4 year: 2022 text: 20220422 day: 22 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Marine drugs |
PublicationTitleAlternate | Mar Drugs |
PublicationYear | 2022 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | ref_94 Kim (ref_35) 2021; 60 Carpena (ref_5) 2021; 117 ref_14 Ye (ref_56) 2020; 48 Wang (ref_80) 2020; 32 ref_98 Li (ref_36) 2020; 11 Sung (ref_47) 2021; 71 Hashimoto (ref_105) 2009; 102 Beppu (ref_107) 2009; 34 Lin (ref_84) 2017; 2017 Terasaki (ref_48) 2017; 61 Yang (ref_8) 2021; 12 ref_25 Dai (ref_40) 2021; 8 ref_24 ref_23 ref_21 Miyashita (ref_109) 2017; 36 Yu (ref_85) 2017; 61 Sharma (ref_63) 2021; 54 Li (ref_6) 2021; 6 Xiang (ref_18) 2017; 65 Willmann (ref_81) 2015; 16 Wu (ref_89) 2021; 2021 ref_72 ref_71 ref_70 Lopes (ref_52) 2020; 40 ref_79 Hitoe (ref_15) 2017; 7 Huang (ref_65) 2021; 46 Liu (ref_99) 2019; 18 ref_75 Chang (ref_16) 2018; 495 Surendraraj (ref_30) 2018; 95 Hosseinzade (ref_31) 2020; 19 Sun (ref_17) 2020; 68 ref_83 Yu (ref_53) 2018; 31 Li (ref_95) 2019; 38 Ma (ref_112) 2019; 4 Ming (ref_60) 2021; 265 Zhao (ref_11) 2017; 42 Terasaki (ref_49) 2021; 41 Dash (ref_82) 2021; 27 Takatani (ref_37) 2020; 528 Kadekaru (ref_108) 2008; 55 Wang (ref_12) 2019; 23 Kinsey (ref_77) 2011; 58 Yang (ref_88) 2021; 69 ref_57 Duncan (ref_96) 2009; 2 Yang (ref_10) 2020; 34 Lewington (ref_78) 2013; 84 Dhami (ref_87) 2021; 18 ref_59 Jiang (ref_41) 2019; 34 Hudlikar (ref_20) 2021; 34 Zhang (ref_91) 2017; 7 Hannan (ref_29) 2020; 13 ref_61 Foo (ref_55) 2019; 21 ref_69 Su (ref_44) 2019; 10 Ghasempour (ref_51) 2018; 4 ref_62 Jin (ref_76) 2019; 80 Almeida (ref_13) 2018; 59 Kuntiya (ref_28) 2013; 8 Guo (ref_64) 2019; 10 Wang (ref_73) 2020; 16 Koo (ref_111) 2016; 64 Strait (ref_93) 2008; 21 Chai (ref_100) 2020; 19 Mohibbullah (ref_19) 2018; 30 Aman (ref_2) 2005; 53 ref_34 ref_33 ref_110 ref_113 Zhang (ref_66) 2018; 48 Hu (ref_90) 2018; 106 Lee (ref_45) 2021; 11 ref_39 ref_38 Yang (ref_67) 2021; 913 Adamczak (ref_26) 2019; 8 Guo (ref_22) 2020; 16 ref_103 ref_106 Chen (ref_54) 2019; 38 Takatani (ref_46) 2021; 65 Wang (ref_58) 2022; 24 ref_43 Alghazwi (ref_86) 2019; 124 Yang (ref_32) 2019; 38 ref_42 ref_102 ref_1 ref_3 Terasaki (ref_50) 2022; 99 Walsh (ref_92) 2006; 24 ref_9 Peng (ref_27) 2011; 9 Yang (ref_97) 2018; 20 ref_4 ref_7 Oliyaei (ref_68) 2021; 9 Asrani (ref_74) 2019; 70 Yang (ref_101) 2021; 199 Zhang (ref_104) 2015; 13 |
References_xml | – volume: 21 start-page: e00296 year: 2019 ident: ref_55 article-title: Increased fucoxanthin in Chaetoceros calcitrans extract exacerbates apoptosis in liver cancer cells via multiple targeted cellular pathways publication-title: Biotechnol. Rep. doi: 10.1016/j.btre.2018.e00296 – volume: 38 start-page: 365 year: 2019 ident: ref_95 article-title: Restorative Effect of Fucoxanthin in an Ovalbumin-Induced Allergic Rhinitis Animal Model through NF-kappaB p65 and STAT3 Signaling publication-title: J. Environ. Pathol. Toxicol. Oncol. doi: 10.1615/JEnvironPatholToxicolOncol.2019030997 – volume: 46 start-page: 171 year: 2021 ident: ref_65 article-title: Effect of fucoxanthin on insulin resistance in obese mice induced by high fat diet publication-title: Zhongguo Zhongyao Zazhi – volume: 2021 start-page: 6688708 year: 2021 ident: ref_89 article-title: Fucoxanthin Prevents 6-OHDA-Induced Neurotoxicity by Targeting Keap1 publication-title: Oxid. Med. Cell. Longev. doi: 10.1155/2021/6688708 – ident: ref_4 doi: 10.3390/molecules26144198 – ident: ref_34 doi: 10.3390/antiox9040328 – volume: 42 start-page: 667 year: 2017 ident: ref_11 article-title: Anti-Neuroinflammatory Effects of Fucoxanthin via Inhibition of Akt/NF-κB and MAPKs/AP-1 Pathways and Activation of PKA/CREB Pathway in Lipopolysaccharide-Activated BV-2 Microglial Cells publication-title: Neurochem. Res. doi: 10.1007/s11064-016-2123-6 – volume: 13 start-page: 6521 year: 2015 ident: ref_104 article-title: Simultaneous Determination of Fucoxanthin and Its Deacetylated Metabolite Fucoxanthinol in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry publication-title: Mar. Drugs doi: 10.3390/md13106521 – volume: 12 start-page: 7235 year: 2021 ident: ref_8 article-title: Role of Fucoxanthin towards Cadmium-induced renal impairment with the antioxidant and anti-lipid peroxide activities publication-title: Bioengineered doi: 10.1080/21655979.2021.1973875 – volume: 34 start-page: 501 year: 2009 ident: ref_107 article-title: Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice publication-title: J. Toxicol. Sci. doi: 10.2131/jts.34.501 – volume: 71 start-page: 209 year: 2021 ident: ref_47 article-title: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21660 – ident: ref_72 doi: 10.3390/md17010069 – volume: 32 start-page: 1896 year: 2020 ident: ref_80 article-title: Antiurolithiatic effect of Fucoxanthin on ethylene glycol-induced renal calculus in experimental rats publication-title: J. King Saud Univ.-Sci. doi: 10.1016/j.jksus.2020.01.027 – volume: 19 start-page: 933 year: 2020 ident: ref_100 article-title: Fucoxanthin improves functional recovery of orbitopathy in Graves’ disease by downregulating IL-17 mRNA expression in a mouse model publication-title: Trop. J. Pharm. Res. doi: 10.4314/tjpr.v19i5.4 – ident: ref_113 doi: 10.3390/md19020092 – volume: 9 start-page: 1806 year: 2011 ident: ref_27 article-title: Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: Metabolism and bioactivities relevant to human health publication-title: Mar. Drugs doi: 10.3390/md9101806 – volume: 31 start-page: 50 year: 2018 ident: ref_53 article-title: Inhibition of two gastric cancer cell lines induced by fucoxanthin involves downregulation of Mcl-1 and STAT3 publication-title: Hum. Cell doi: 10.1007/s13577-017-0188-4 – volume: 21 start-page: 521 year: 2008 ident: ref_93 article-title: Suppression of NF-κB activation blocks osteoclastic bone resorption during estrogen deficiency publication-title: Int. J. Mol. Med. – ident: ref_1 doi: 10.3390/md19110606 – volume: 65 start-page: 4092 year: 2017 ident: ref_18 article-title: Fucoxanthin Inhibits β-Amyloid Assembly and Attenuates β-Amyloid Oligomer-Induced Cognitive Impairments publication-title: J. Agric. Food Chem. doi: 10.1021/acs.jafc.7b00805 – volume: 53 start-page: 9512 year: 2005 ident: ref_2 article-title: Effects of heating and illumination on trans-cis isomerization and degradation of beta-carotene and lutein in isolated spinach chloroplasts publication-title: J. Agric. Food Chem. doi: 10.1021/jf050926w – ident: ref_79 doi: 10.3390/md17120702 – volume: 102 start-page: 242 year: 2009 ident: ref_105 article-title: The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice publication-title: Br. J. Nutr. doi: 10.1017/S0007114508199007 – volume: 10 start-page: 5644 year: 2019 ident: ref_64 article-title: Fucoxanthin modulates cecal and fecal microbiota differently based on diet publication-title: Food Funct. doi: 10.1039/C9FO01018A – volume: 30 start-page: 3243 year: 2018 ident: ref_19 article-title: Neuroprotective effects of fucoxanthin and its derivative fucoxanthinol from the phaeophyte Undaria pinnatifida attenuate oxidative stress in hippocampal neurons publication-title: J. Appl. Phycol. doi: 10.1007/s10811-018-1458-6 – volume: 4 start-page: 10502 year: 2019 ident: ref_112 article-title: Fucoxanthin-Loaded Oil-in-Water Emulsion-Based Delivery Systems: Effects of Natural Emulsifiers on the Formulation, Stability, and Bioaccessibility publication-title: ACS Omega doi: 10.1021/acsomega.9b00871 – volume: 58 start-page: 291 year: 2011 ident: ref_77 article-title: Pathogenesis of acute kidney injury: Foundation for clinical practice publication-title: Am. J. Kidney Dis. doi: 10.1053/j.ajkd.2011.02.385 – ident: ref_14 doi: 10.3390/jcm9010090 – volume: 27 start-page: 383 year: 2021 ident: ref_82 article-title: Phytosterols: Targeting neuroinflammation in neurodegeneration publication-title: Curr. Pharm. Des. doi: 10.2174/1381612826666200628022812 – volume: 64 start-page: 9428 year: 2016 ident: ref_111 article-title: Preparation of Fucoxanthin-Loaded Nanoparticles Composed of Casein and Chitosan with Improved Fucoxanthin Bioavailability publication-title: J. Agric. Food Chem. doi: 10.1021/acs.jafc.6b04376 – volume: 13 start-page: 116 year: 2020 ident: ref_29 article-title: Neuroprotection Against Oxidative Stress: Phytochemicals Targeting TrkB Signaling and the Nrf2-ARE Antioxidant System publication-title: Front. Mol. Neurosci. doi: 10.3389/fnmol.2020.00116 – volume: 117 start-page: 163 year: 2021 ident: ref_5 article-title: Biological action mechanisms of fucoxanthin extracted from algae for application in food and cosmetic industries publication-title: Trends Food Sci. Technol. doi: 10.1016/j.tifs.2021.03.012 – volume: 9 start-page: 3521 year: 2021 ident: ref_68 article-title: Antidiabetic effect of fucoxanthin extracted from Sargassum angustifolium on streptozotocin-nicotinamide-induced type 2 diabetic mice publication-title: Food Sci. Nutr. doi: 10.1002/fsn3.2301 – ident: ref_69 doi: 10.3390/jcm11041136 – volume: 24 start-page: 30 year: 2022 ident: ref_58 article-title: Nfe2l2 Regulates Metabolic Rewiring and Epigenetic Reprogramming in Mediating Cancer Protective Effect by Fucoxanthin publication-title: AAPS J. doi: 10.1208/s12248-022-00679-0 – ident: ref_59 doi: 10.3390/molecules26144288 – ident: ref_94 doi: 10.3390/md19030132 – volume: 7 start-page: srep46763 year: 2017 ident: ref_91 article-title: Fucoxanthin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE and Nrf2-autophagy pathways publication-title: Sci. Rep. doi: 10.1038/srep46763 – volume: 20 start-page: 32 year: 2018 ident: ref_97 article-title: Fucoxanthin Elicits Epigenetic Modifications, Nrf2 Activation and Blocking Transformation in Mouse Skin JB6 P+ Cells publication-title: AAPS J. doi: 10.1208/s12248-018-0197-6 – volume: 11 start-page: 543 year: 2021 ident: ref_45 article-title: Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation publication-title: Sci. Rep. doi: 10.1038/s41598-020-80748-6 – volume: 16 start-page: 214 year: 2020 ident: ref_73 article-title: Fucoxanthin averts isoprenaline hydrochloride-induced myocardial infarction in rats publication-title: Pharmacogn. Mag. – ident: ref_98 doi: 10.3390/ijms21062180 – ident: ref_61 doi: 10.3390/nu11040796 – ident: ref_75 doi: 10.1186/s12906-018-2164-2 – volume: 199 start-page: 1877 year: 2021 ident: ref_101 article-title: Effect of Fucoxanthin Administration on Thyroid Gland Injury Induced by Cadmium in Mice publication-title: Biol. Trace Elem. Res. doi: 10.1007/s12011-020-02291-9 – volume: 61 start-page: 1304678 year: 2017 ident: ref_85 article-title: Fucoxanthin prevents H2O2-induced neuronal apoptosis via concurrently activating the PI3-K/Akt cascade and inhibiting the ERK pathway publication-title: Food Nutr. Res. doi: 10.1080/16546628.2017.1304678 – volume: 6 start-page: 100245 year: 2021 ident: ref_6 article-title: Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells publication-title: J. Agric. Food Res. – ident: ref_38 doi: 10.3390/md19060334 – volume: 48 start-page: 300060520964011 year: 2020 ident: ref_56 article-title: Fucoxanthin may inhibit cervical cancer cell proliferation via downregulation of HIST1H3D publication-title: J. Int. Med. Res. doi: 10.1177/0300060520964011 – volume: 2 start-page: 665 year: 2009 ident: ref_96 article-title: Topical treatment with black raspberry extract reduces cutaneous UVB-induced carcinogenesis and inflammation publication-title: Cancer Prev. Res. doi: 10.1158/1940-6207.CAPR-08-0193 – ident: ref_103 doi: 10.3390/md17050304 – ident: ref_70 doi: 10.3390/md19060307 – ident: ref_71 doi: 10.3390/biomedicines9060620 – volume: 124 start-page: 215 year: 2019 ident: ref_86 article-title: In vitro studies of the neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (Aβ 1-42 ) toxicity and aggregation publication-title: Neurochem. Int. doi: 10.1016/j.neuint.2019.01.010 – ident: ref_3 doi: 10.3390/ijms20184485 – ident: ref_23 doi: 10.3390/antiox9121176 – volume: 18 start-page: 623 year: 2021 ident: ref_87 article-title: Neuroprotective Effect of Fucoxanthin against Intracerebroventricular Streptozotocin (ICV-STZ) Induced Cognitive Impairment in Experimental Rats publication-title: Curr. Alzheimer Res. doi: 10.2174/1567205018666211118144602 – ident: ref_42 doi: 10.3390/md17030152 – ident: ref_102 doi: 10.3390/nu13041079 – volume: 24 start-page: 33 year: 2006 ident: ref_92 article-title: Osteoimmunology: Interplay between the immune system and bone metabolism publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.immunol.24.021605.090646 – volume: 18 start-page: 926 year: 2019 ident: ref_99 article-title: Fucoxanthin isolated from Undaria pinnatifida can interact with Escherichia coli and lactobacilli in the intestine and inhibit the growth of pathogenic bacteria publication-title: J. Ocean Univ. China doi: 10.1007/s11802-019-4019-y – volume: 84 start-page: 457 year: 2013 ident: ref_78 article-title: Raising awareness of acute kidney injury: A global perspective of a silent killer publication-title: Kidney Int. doi: 10.1038/ki.2013.153 – volume: 265 start-page: 113302 year: 2021 ident: ref_60 article-title: Fucoxanthin extracted from Laminaria Japonica inhibits metastasis and enhances the sensitivity of lung cancer to Gefitinib publication-title: J. Ethnopharmacol. doi: 10.1016/j.jep.2020.113302 – ident: ref_25 doi: 10.3390/md16090323 – ident: ref_33 doi: 10.3390/antiox10071092 – volume: 38 start-page: 239 year: 2019 ident: ref_54 article-title: Anti-inflammatory and apoptotic signaling effect of fucoxanthin on benzo(A)pyrene-induced lung cancer in mice publication-title: J. Environ. Pathol. Toxicol. Oncol. doi: 10.1615/JEnvironPatholToxicolOncol.2019030301 – volume: 99 start-page: 108871 year: 2022 ident: ref_50 article-title: Suppression of C-C chemokine receptor 1 is a key regulation for colon cancer chemoprevention in AOM/DSS mice by fucoxanthin publication-title: J. Nutr. Biochem. doi: 10.1016/j.jnutbio.2021.108871 – volume: 69 start-page: 9764 year: 2021 ident: ref_88 article-title: PLGA-PEG Nanoparticles Facilitate in Vivo Anti-Alzheimer’s Effects of Fucoxanthin, a Marine Carotenoid Derived from Edible Brown Algae publication-title: J. Agric. Food Chem. doi: 10.1021/acs.jafc.1c00569 – volume: 10 start-page: 906 year: 2019 ident: ref_44 article-title: Fucoxanthin, a marine xanthophyll isolated from Conticribra weissflogii ND-8: Preventive anti-inflammatory effect in a mouse model of sepsis publication-title: Front. Pharmacol. doi: 10.3389/fphar.2019.00906 – ident: ref_62 doi: 10.3390/md17050311 – volume: 2017 start-page: 6792543 year: 2017 ident: ref_84 article-title: Fucoxanthin, a Marine Carotenoid, Attenuates β -Amyloid Oligomer-Induced Neurotoxicity Possibly via Regulating the PI3K/Akt and the ERK Pathways in SH-SY5Y Cells publication-title: Oxid. Med. Cell. Longev. doi: 10.1155/2017/6792543 – volume: 34 start-page: 713 year: 2021 ident: ref_20 article-title: Epigenomic, Transcriptomic, and Protective Effect of Carotenoid Fucoxanthin in High Glucose-Induced Oxidative Stress in Mes13 Kidney Mesangial Cells publication-title: Chem. Res. Toxicol. doi: 10.1021/acs.chemrestox.0c00235 – volume: 60 start-page: 3315 year: 2021 ident: ref_35 article-title: Fucoxanthin inhibits lipopolysaccharide-induced inflammation and oxidative stress by activating nuclear factor E2-related factor 2 via the phosphatidylinositol 3-kinase/AKT pathway in macrophages publication-title: Eur. J. Nutr. doi: 10.1007/s00394-021-02509-z – ident: ref_39 doi: 10.3390/pharmaceutics12020136 – volume: 106 start-page: 1484 year: 2018 ident: ref_90 article-title: Neuroprotective role of fucoxanthin against cerebral ischemic/reperfusion injury through activation of Nrf2/HO-1 signaling publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2018.07.088 – ident: ref_9 doi: 10.3390/md17100552 – volume: 19 start-page: 2901 year: 2020 ident: ref_31 article-title: Optimization of production and antioxidant activity of fucoxanthin from marine haptophyte algae, Isochrysis galbana publication-title: Iran. J. Fish. Sci. – volume: 61 start-page: 25 year: 2017 ident: ref_48 article-title: A marine bio-functional lipid, fucoxanthinol, attenuates human colorectal cancer stem-like cell tumorigenicity and sphere formation publication-title: J. Clin. Biochem. Nutr. doi: 10.3164/jcbn.16-112 – volume: 80 start-page: 209 year: 2019 ident: ref_76 article-title: Protective role of fucoxanthin in diethylnitrosamine-induced hepatocarcinogenesis in experimental adult rats publication-title: Drug Dev. Res. doi: 10.1002/ddr.21451 – volume: 16 start-page: 277 year: 2015 ident: ref_81 article-title: Ultraviolet Keratitis: From the Pathophysiological Basis to Prevention and Clinical Management publication-title: High Alt. Med. Biol. doi: 10.1089/ham.2015.0109 – volume: 55 start-page: 304 year: 2008 ident: ref_108 article-title: Safety evaluation of fucoxanthin purified from Undaria pinnatifida publication-title: Nippon Shokuhin Kagaku Kogaku Kaishi doi: 10.3136/nskkk.55.304 – volume: 8 start-page: 1381 year: 2013 ident: ref_28 article-title: Anticholinesterase and antioxidant activities of fucoxanthin purified from the microalga Phaeodactylum tricornutum publication-title: Nat. Prod. Commun. – volume: 528 start-page: 305 year: 2020 ident: ref_37 article-title: Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2020.05.050 – volume: 11 start-page: 3361 year: 2020 ident: ref_36 article-title: Fucoxanthin alleviates palmitate-induced inflammation in RAW 264.7 cells through improving lipid metabolism and attenuating mitochondrial dysfunction publication-title: Food Funct. doi: 10.1039/D0FO00442A – volume: 48 start-page: 515 year: 2018 ident: ref_66 article-title: Fucoxanthin ameliorates hyperglycemia, hyperlipidemia and insulin resistance in diabetic mice partially through IRS-1/PI3K/Akt and AMPK pathways publication-title: J. Funct. Foods doi: 10.1016/j.jff.2018.07.048 – volume: 95 start-page: 835 year: 2018 ident: ref_30 article-title: Isolation of Fucoxanthin from Brown Algae and Its Antioxidant Activity: In Vitro and 5% Fish Oil-In-Water Emulsion publication-title: JAOCS J. Am. Oil Chem. Soc. doi: 10.1002/aocs.12092 – volume: 495 start-page: 197 year: 2018 ident: ref_16 article-title: Fucoxanthin attenuates fatty acid-induced lipid accumulation in FL83B hepatocytes through regulated Sirt1/AMPK signaling pathway publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2017.11.022 – ident: ref_106 doi: 10.3390/md18110557 – volume: 40 start-page: 6799 year: 2020 ident: ref_52 article-title: Anti-cancer effects of fucoxanthin on human glioblastoma cell line publication-title: Anticancer Res. doi: 10.21873/anticanres.14703 – ident: ref_83 doi: 10.20944/preprints202005.0342.v1 – volume: 38 start-page: 229 year: 2019 ident: ref_32 article-title: Assessment of the Therapeutic Effects of Fucoxanthin by Attenuating Inflammation in Ovalbumin-Induced Asthma in an Experimental Animal Model publication-title: J. Environ. Pathol. Toxicol. Oncol. doi: 10.1615/JEnvironPatholToxicolOncol.2019030154 – volume: 8 start-page: 349 year: 2021 ident: ref_40 article-title: Fucoxanthin-rich fraction from Sargassum fusiformis alleviates particulate matter-induced inflammation in vitro and in vivo publication-title: Toxicol. Rep. doi: 10.1016/j.toxrep.2021.02.005 – volume: 8 start-page: 239 year: 2019 ident: ref_26 article-title: Fucoxanthin—An Antibacterial Carotenoid publication-title: Antioxidants doi: 10.3390/antiox8080239 – ident: ref_24 doi: 10.3390/md16100378 – volume: 54 start-page: 102187 year: 2021 ident: ref_63 article-title: Polysaccharide (laminaran and fucoidan), fucoxanthin and lipids as functional components from brown algae (Padina tetrastromatica) modulates adipogenesis and thermogenesis in diet-induced obesity in C57BL6 mice publication-title: Algal. Res. doi: 10.1016/j.algal.2021.102187 – ident: ref_7 doi: 10.3390/antiox8060183 – volume: 70 start-page: 151 year: 2019 ident: ref_74 article-title: Burden of liver diseases in the world publication-title: J. Hepatol. doi: 10.1016/j.jhep.2018.09.014 – volume: 34 start-page: 1791 year: 2020 ident: ref_10 article-title: Anti-inflammatory effect of fucoxanthin on dextran sulfate sodium-induced colitis in mice publication-title: Nat. Prod. Res. doi: 10.1080/14786419.2018.1528593 – volume: 7 start-page: 246 year: 2017 ident: ref_15 article-title: Seaweed fucoxanthin supplementation improves obesity parameters in mild obese Japanese subjects publication-title: Funct. Foods Health Dis. doi: 10.31989/ffhd.v7i4.333 – volume: 913 start-page: 174629 year: 2021 ident: ref_67 article-title: Fucoxanthin regulates Nrf2 signaling to decrease oxidative stress and improves renal fibrosis depending on Sirt1 in HG-induced GMCs and STZ-induced diabetic rats publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2021.174629 – volume: 36 start-page: 195 year: 2017 ident: ref_109 article-title: Fucoxanthin in the management of obesity and its related disorders publication-title: J. Funct. Foods doi: 10.1016/j.jff.2017.07.009 – volume: 68 start-page: 5118 year: 2020 ident: ref_17 article-title: Modulation of Gut Microbiota by Fucoxanthin during Alleviation of Obesity in High-Fat Diet-Fed Mice publication-title: J. Agric. Food Chem. doi: 10.1021/acs.jafc.0c01467 – volume: 59 start-page: 24 year: 2018 ident: ref_13 article-title: Cytotoxic activity of fucoxanthin, alone and in combination with the cancer drugs imatinib and doxorubicin, in CML cell lines publication-title: Environ. Toxicol. Pharmacol. doi: 10.1016/j.etap.2018.02.006 – volume: 34 start-page: 431 year: 2019 ident: ref_41 article-title: Fucoxanthin prevents lipopolysaccharide-induced depressive-like behavior in mice via AMPK- NF-κB pathway publication-title: Metab. Brain Dis. doi: 10.1007/s11011-018-0368-2 – ident: ref_110 doi: 10.3390/foods9081113 – volume: 23 start-page: 2219 year: 2019 ident: ref_12 article-title: Fucoxanthin inhibits tumour-related lymphangiogenesis and growth of breast cancer publication-title: J. Cell. Mol. Med. doi: 10.1111/jcmm.14151 – ident: ref_21 doi: 10.1016/j.jff.2019.103542 – volume: 65 start-page: 405 year: 2021 ident: ref_46 article-title: Identification of Paracentrone in Fucoxanthin-Fed Mice and Anti-Inflammatory Effect against Lipopolysaccharide-Stimulated Macrophages and Adipocytes publication-title: Mol. Nutr. Food Res. doi: 10.1002/mnfr.202000405 – ident: ref_57 doi: 10.3390/ijms222413620 – volume: 4 start-page: 81 year: 2018 ident: ref_51 article-title: In vitro investigating of anticancer activity of focuxanthin from marine brown seaweed species publication-title: Glob. J. Environ. Sci. Manag. – ident: ref_43 doi: 10.3390/cells10061311 – volume: 16 start-page: 242 year: 2020 ident: ref_22 article-title: Protective effect of fucoxanthin on ovariectomy-induced osteoporosis in rats publication-title: Pharmacogn. Mag. – volume: 41 start-page: 1299 year: 2021 ident: ref_49 article-title: Fucoxanthin prevents colorectal cancer development in dextran sodium sulfate-treated ApcMin/+ mice publication-title: Anticancer Res. doi: 10.21873/anticanres.14887 |
SSID | ssj0035894 |
Score | 2.5493443 |
SecondaryResourceType | review_article |
Snippet | Fucoxanthin, belonging to the xanthophyll class of carotenoids, is a natural antioxidant pigment of marine algae, including brown macroalgae and diatoms. It... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 279 |
SubjectTerms | Algae Anticancer properties Antioxidants Antitumor agents bioactivities Biocompatibility Cancer Carotenoids Chemical kinetics Diabetes mellitus Diatoms Disease prevention Fucoxanthin Functional foods & nutraceuticals Heart diseases Herbal medicine Human subjects Humans in vitro in vivo Inflammation Marine microorganisms Metabolism Metabolites Microorganisms Molecular modelling Neoplasms Nervous system Obesity Oxidative stress Pharmaceuticals Pharmacokinetics Pharmacology Review safety and toxicity Scientific papers Seaweed - chemistry Skin diseases Toxicity Tumors Xanthophylls Xanthophylls - chemistry Xanthophylls - pharmacology Xanthophylls - therapeutic use |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yT76I31ZPiSgHwhXTNk03vq0fyymcHHgL92SZfHkHR3q4u-L998403e6uHPjiazOUdGYyM78m8wtjr0XQxuumyDFbSQQoMMnB2zqvLUZDEJUFRw3Ox1_V0Vx-OavPtq76ojNhiR44Ke6tq5yxurRQO4dQQhilnPVBCxDS1xAo-mLOW4OpFIOreqJlIiOtENQjuKefJ4jA9E766Vn6byot_z4huZVyZnfZnaFW5NM0x3vslo_32cFJIpu-PuSnm96pxSE_4CcbGurrB-z7lH8baZp52gPgXeTHQA1_fHr5A3z-ER3wl3d8trLdb1Ty-UV8x6eRz6_oTwDvwvZLyZ78c1wQnl88ZPPZp9MPR_lwm0JuZVMuc4PAwmqvfAPOAqLiQvqAKRJMJVyjjajBiKAc7W9NRAjGGIA6NMYXFqwS1SO2F7vonzAuTdMXFwasl4h_tLSyMF5JKG1RNC5jb9ZKbu1ANU43Xly2CDnIIO3GIBl7NcpeJYKNG6Xek61GCSLF7h-gq7SDq7T_cpWM7a8t3Q4rddGWCmMeakOqjL0ch3GN0cYJRN-tehniwcdKJ2OPk2OMM6mwgMQiWGSs2XGZnanujsSL857HW1OWUpOn_-PbnrHbJTVmCJmX5T7bW_5c-edYLi3Ni35l_AHLORjy priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0vvgitn6l1rKiFIQubpLN5tYXOT-OKlQK9uCeDLMfaQslOZs7af97Z5JcrifF1-wQlp3ZnfnN7vyGsbeyNDaYPBborRQCFBgJCC4TmcPTEGTqwFOB8_EPfTRV32fZrE-4Nf2zytWZ2B7UvnaUI3-faLRNxHJKf5z_FtQ1im5X-xYa99kDoi6jJ135bABcaTYyqqMkTRHaI8SnFAriMLPhhFqu_rsCzH_fSd5yPJPH7FEfMfJxp-Jtdi9UO-zgpKOcvjnkp-sKquaQH_CTNRn1zRP2a8x_DmTNvLsJ4HXFj4HK_vj48gyC-IJm-Cd4Plm6-hqX-vyi-sDHFZ_OKR_A6_L2T0mr_FvVEKpvnrLp5Ovp5yPR91QQTuXJQliEF84EHXLwDnA9YxVKdJRgU-lzY2UGVpba0y3XSJaltRYgK3MbYgdOy_QZ26rqKrxgXNm8DTEsuKAQBRnlVGyDVpC4OM59xN6tFrlwPeE49b24LBB4kEKKtUIi9maQnXc0G3dKfSJdDRJEjd1-qK_Oin6nFT711pnEQeY9Yk9ptUYFlkaCVCGDMmJ7K00X_X5tirV1Rez1MIw7ja5PoAr1spUhNnyMdyL2vDOMYSYphpEYCsuI5RsmszHVzZHq4rxl8zbkq_Ro9__TeskeJlR4IZVIkj22tbhahlcYDi3sfmvzfwHpuQ6V priority: 102 providerName: ProQuest |
Title | A Systematic Review on Marine Algae-Derived Fucoxanthin: An Update of Pharmacological Insights |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35621930 https://www.proquest.com/docview/2670346946 https://www.proquest.com/docview/2671275521 https://pubmed.ncbi.nlm.nih.gov/PMC9146768 https://doaj.org/article/d3dbc92ca5dd4480b66dcef90a04e5af |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Za9tAEB5yvPSlND3VpmZLS6AQlZW02rUKpThtTFpwMG0MfqrYMwkYKfUR4n_fWUmW4-CHvmpHBzM7O_PtaL8B-EBdpmwmohCjFUOAIruhtDoNU42roaSJlsYfcB6c87MR-zlOxzuw6t_ZKHC2Fdr5flKj6eTT3d_lV3T4Lx5xImRH6O63RhBfZbuwjxFJeAcdsLaakKTdqiFixDmuORiAa5rSB_duBKaKv39b0vnw38l7waj_BB43WSTp1WY_gB1bPIWjYU1DvTwmF-tTVbNjckSGa4Lq5TP40yO_WwJnUlcHSFmQgfRHAUlvcilt-B2n5q01pL_Q5R2q_-q6-Ex6BRnd-D0CUrr7D_WWJj-KmUf6s-cw6p9efDsLmz4LoWYinocKIYfOLLdCGi0RL0fMOgyeUiXUiEzRVCrquPGVry51TiklZeqEspGWmtPkBewVZWFfAWFKVGmHktoyREYZ0yxSljMZ6ygSJoCPKyXnuiEh970wJjmCEW-QfG2QAN63sjc19cZWqRNvq1bC02VXF8rpZd54X24So3QWa5kag3iUKs7RgC6jkjKbShfA4crS-WoK5jHH1RC1wXgA79ph9D5fUpGFLReVjGfIxxwogJf1xGi_JMHUEtNjGoDYmDIbn7o5UlxfVQzfmY9fvPv6P977Bh7F_kQGZWEcH8LefLqwbzFPmqsO7Iqx6MD-yen58Fen2m3oVI7xD0XGF6g |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6V9AAXxBtDgUVAJaRaXdtrO4uEUEobJbSJIkiknjD7clup2KFJgPwpfiOzfqVBFbdevaPVyvOe3fkG4DVNuTQ89lz0VgwTFNF2hVGhGyq0hoIGSmjb4DwYRr0J-3QcHm_An7oXxj6rrG1iYah1rmyNfNePUDYxl2PRh-kP106Nsrer9QiNUiwOzfIXpmyz9_195O8b3-8ejD_23GqqgKtY7M9diQG24iYysdBK4I4eMym6CiEDqmMuaSgkTSNt73naNE2llEKEaSyNp4SKaID73oBNFmAq04LNvYPh6HNt-4OwzVkJghoEnO5-17Zog5kfX3N7xXSAq0Laf19mXnJ13Ttwu4pRSacUqruwYbJ7sD0qQa6XO2S86tma7ZBtMlrBXy_vw9cO-dLAQ5Py7oHkGRkI22hIOucnwrj7KPg_jSbdhcp_I3NPz7J3pJORydRWIEieXt7UyhHpZzNbR5g9gMm1_O-H0MryzDwGwmRcBDVSKMMw7-JMMU-aiAlfeV6sHXhb_-REVRDndtLGeYKpjmVIsmKIA68a2mkJ7HEl1Z7lVUNhwbiLD_nFSVLpdqIDLRX3lQi1xmyXyihCBqacCspMKFIHtmpOJ5WFmCUreXbgZbOMum0vbERm8kVBY_H3McJy4FEpGM1JAgxcMfimDsRrIrN21PWV7Oy0wA_n1jtG7Sf_P9YLuNkbD46So_7w8Cnc8m3bB2Wu729Ba36xMM8wGJvL55UGEPh23Ur3F20uUC4 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1baxNBFD7UCuKLeHe16ohaELpkdnd2NiOIRGNorC0BG8hT17ltW6i7sUnU_DV_nWf2lkaKb33dOQzDnvuZOd8BeEUzoaxIAh-9FcMERXZ9aXXsxxqtoaSRlsY1OO8f8N0x-zyJJxvwp-mFcc8qG5tYGmpTaFcj74QcZRNzOcY7Wf0sYtQfvJ_-8N0EKXfT2ozTqERkzy5_Yfo2ezfsI69fh-Hg0-HHXb-eMOBrloRzX2GwrYXlNpFGS9w9YDZDtyFVRE0iFI2lohk37s6nS7NMKSVlnCXKBlpqTiPc9xpcT6I4cDqWTNpkL4q7glVwqFEkaOe7ceUbzAHFmgMs5wRcFtz--0bzgtMb3IZbdbRKepV43YENm9-F7VEFd73cIYer7q3ZDtkmoxUQ9vIeHPXI1xYomlS3EKTIyb50LYekd3Ysrd9HFfhpDRksdPEb2Xxymr8lvZyMp64WQYrs4qZOosgwn7mKwuw-jK_kbz-AzbzI7SMgTCVleKOktgwzMME0C5TlTIY6CBLjwZvmJ6e6Bjt3MzfOUkx6HEPSFUM8eNnSTiuIj0upPjhetRQOlrv8UJwfp7WWpyYySotQy9gYzHup4hwZmAkqKbOxzDzYajid1rZilq4k24MX7TJqubu6kbktFiWNQ-LHWMuDh5VgtCeJMITFMJx6kKyJzNpR11fy05MSSVw4P8m7j_9_rOdwA1Ut_TI82HsCN0PX_0GZH4ZbsDk_X9inGJXN1bNS_Al8u2p9-wvwglL- |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Systematic+Review+on+Marine+Algae-Derived+Fucoxanthin%3A+An+Update+of+Pharmacological+Insights&rft.jtitle=Marine+drugs&rft.au=Mohibbullah%2C+Md&rft.au=Haque%2C+Md+Nazmul&rft.au=Sohag%2C+Abdullah+Al+Mamun&rft.au=Hossain%2C+Md+Tahmeed&rft.date=2022-04-22&rft.issn=1660-3397&rft.eissn=1660-3397&rft.volume=20&rft.issue=5&rft_id=info:doi/10.3390%2Fmd20050279&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1660-3397&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1660-3397&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1660-3397&client=summon |